Skip to main content
NAGE $1.87 -3.74%
NAGE logo
NAGE · Niagen Bioscience, Inc.
Track NAGE — free
$1.87 -0.07 (-3.74%) Play latest call Q3 2026 earnings call transcript
Market Cap
$153.64M
Shares
79.20M
Volume · Nov 19 196.29K Avg daily vol (3M) 511.23K
All webcasts

Earnings call · FY2024 Q2

Niagen Bioscience, Inc. (NAGE) Q2 2024 Earnings Call

Concluded Aug 7, 2024
Aug 7, 2024
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
Revenue $22.74M +11.9% YoY
Diluted EPS $0.00
Gross margin 60.2% -0.6 pp YoY
Net income -$15,000
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 7, 2024.

Metric Guided
Revenue growth
full year 2024
10% – 15%

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Consumer Products Segment$18.65M +10.4% YoY
Ingredients Segment$3.30M +22.1% YoY
Analytical Reference Standards and Services Segment$791,000 +8.7% YoY
Full-screen source Call document